Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ SRSF6 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA5103322
Description
Antibody detects endogenous levels of total SFRS6.
SFRS6 is involved in mRNA splicing and may play a role in the determination of alternative splicing. It belongs to the splicing factor SR family and has been shown to bind with and modulate another member of the family, SFRS12. The protein encoded by this gene is involved in mRNA splicing and may play a role in the determination of alternative splicing. The encoded nuclear protein belongs to the splicing factor SR family and has been shown to bind with and modulate another member of the family, SFRS12.
Specifications
SRSF6 | |
Polyclonal | |
Unconjugated | |
Srsf6 | |
1210001E11Rik; AI314910; AW146126; B52; epididymis secretory protein Li 91; HEL-S-91; LOW QUALITY PROTEIN: serine/arginine-rich splicing factor 6; MGC5045; pre-mRNA-splicing factor SRP55; serine and arginine rich splicing factor 6; serine/arginine-rich splicing factor 6; serine/arginine-rich splicing factor 6-like protein; Sfrs6; splicing factor SRp55; splicing factor SRp55 homolog; splicing factor SRp55-1; splicing factor, arginine/serine-rich 6; splicing factor, arginine/serine-rich, 55 kDa; SR splicing factor 6; SRP55; SRP55-1; SRSF6 | |
Rabbit | |
Affinity Chromatography | |
RUO | |
362264, 6431, 67996 | |
-20°C | |
Liquid |
Western Blot | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
G3V6S8, Q13247, Q3TWW8 | |
Srsf6 | |
A synthesized peptide derived from human SRSF6(Accession Q13247), corresponding to amino acid residues S228-S278. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction